Doppler study of hepatic vein in cirrhotic patients: correlation with liver dysfunction and hepatic hemodynamics

K-C Sudhamshu1, Shoiichi Matsutani, Hitoshi Maruyama

  • 1Liver Unit, Department of Medicine, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal. sudhamshu@hotmail.com

Insights

Doppler measurements of the hepatic vein in liver cirrhosis patients show significantly higher mean velocities compared to controls. This velocity increase correlates with cirrhosis severity and ascites, suggesting its utility in assessing liver disease progression.

Area of Science:

  • Medical imaging
  • Hepatology
  • Cardiovascular physiology

Background:

  • Liver cirrhosis significantly alters hepatic hemodynamics.
  • Assessing the severity of liver dysfunction and its impact on circulation is crucial.

Purpose of the Study:

  • To investigate the diagnostic significance of hepatic vein Doppler measurements in liver cirrhosis.
  • To correlate these measurements with liver dysfunction and hemodynamic changes.

Main Methods:

  • Doppler ultrasonography was performed on 100 cirrhotic patients and 60 controls.
  • Hepatic vein, portal trunk, portal vein, and hepatic artery flow velocities were measured.
  • Hepatic vein waveforms were classified, and mean flow velocity was analyzed.

Main Results:

  • Mean hepatic vein velocity was significantly elevated in cirrhotic patients (12.7 cm/s) versus controls (5.1-6.2 cm/s).
  • Higher velocities correlated with poorer cirrhosis grade and increased ascites.
  • Significant correlation found between right portal flow and mean hepatic vein velocity (r=0.687).

Conclusions:

  • Hepatic vein Doppler velocity, measured during normal respiration, is independent of liver dysfunction.
  • Mean hepatic vein velocity serves as a valuable indicator of altered hepatic circulation in cirrhosis.
  • This measurement can be a novel parameter for assessing liver cirrhosis progression.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...